miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma

miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma

miR-125b, ubiquitously expressed and frequently dysregulated in several tumors, has gained special interest in the field of cancer research, displaying either oncogenic or oncosuppressor potential based on tumor type. We have previously demonstrated its tumor-suppressive role in multiple myeloma (MM...

Full description

Bibliographic Details
Main Authors:	Gabriella Misso, Mayra Rachele Zarone, Angela Lombardi, Anna Grimaldi, Alessia Maria Cossu, Carmela Ferri, Margherita Russo, Daniela Cristina Vuoso, Amalia Luce, Hiromichi Kawasaki, Maria Teresa Di Martino, Antonella Virgilio, Agostino Festa, Aldo Galeone, Giuseppe De Rosa, Carlo Irace, Massimo Donadelli, Alois Necas, Evzen Amler, Pierosandro Tagliaferri, Pierfrancesco Tassone, Michele Caraglia
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	Molecular Therapy: Nucleic Acids
Online Access:	http://www.sciencedirect.com/science/article/pii/S216225311930054X

Similar Items

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
by: Daniele Caracciolo, et al.
Published: (2021-08-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
by: Marianna Abate, et al.
Published: (2023-09-01)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
by: Bolayırlı Ibrahim Murat, et al.
Published: (2022-01-01)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
by: Kristoffer Unterbruner, et al.
Published: (2018-01-01)

Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma
by: Nicola Amodio, et al.
Published: (2019-02-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

Expression of miR-145, miR-146, and miR-155 in an experimental model of arteriovenous fistula
by: Hugo Laparra-Escareño, et al.
Published: (2022-01-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.
by: Maria Teresa Di Martino, et al.
Published: (2014-01-01)

miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
by: Tatiana A. Petrova, et al.
Published: (2022-12-01)

Diagnostic performance of miR-21, miR-124, miR-132, and miR-200b serums in post-stroke cognitive impairment patients
by: Mei Yuan, et al.
Published: (2022-06-01)

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
by: Xi Zeng, et al.
Published: (2012-01-01)

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
by: Maria Eugenia Gallo Cantafio, et al.
Published: (2016-01-01)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2019-03-01)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
by: Thorben Fründt, et al.
Published: (2021-05-01)

Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women
by: Jeong Yong Lee, et al.
Published: (2019-12-01)

Age-Related Exosomal and Endogenous Expression Patterns of miR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles
by: Chrystalla Mytidou, et al.
Published: (2021-11-01)

miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth Restriction
by: Salvatore Tagliaferri, et al.
Published: (2021-03-01)

Alterations in the Expression Profile of Serum miR-155, miR-223, miR-17, miR-200a, miR-205, as well as Levels of Interleukin 6, and Prostaglandins during Endometritis in Arabian Mares
by: Sally Ibrahim, et al.
Published: (2021-06-01)

Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice
by: Andras Tomesz, et al.
Published: (2022-03-01)

Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis
by: Zahra Saadatian, et al.
Published: (2023-10-01)

Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
by: Xin He, et al.
Published: (2022-01-01)

miR-221, miR-650 and miR-4534 as diagnostic markers in prostate cancer and their relationship with lymphatic invasion
by: Hekımler Öztürk Kuyaş, et al.
Published: (2022-03-01)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
by: Parisa Bayat, et al.
Published: (2023-02-01)

The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke
by: Aya Tarek Salman, et al.
Published: (2022-12-01)

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
by: Sunyoung Park, et al.
Published: (2017-09-01)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
by: Pernille Bækgaard Udesen1, et al.
Published: (2020-12-01)

Association of miR-146a, miR-149, miR-196a2, and miR-499 Polymorphisms with Ossification of the Posterior Longitudinal Ligament of the Cervical Spine.
by: Jae Joon Lim, et al.
Published: (2016-01-01)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
by: Paulina López, et al.
Published: (2018-05-01)

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
by: Yasuo Takashima, et al.
Published: (2020-01-01)

Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis
by: Taha Aghajanzadeh, et al.
Published: (2023-12-01)

MiR-612, miR-637, and miR-874 can Regulate VEGFA Expression in Hepatocellular Carcinoma Cell Lines
by: Márcia Maria U. Castanhole-Nunes, et al.
Published: (2022-01-01)

Evaluation of the clinical value of circulating miR-101, miR-187 and miR-21 in neonatal sepsis diagnosis and prognosis
by: Rabab F. Salim, et al.
Published: (2020-03-01)